News
Five University of Kentucky faculty members received the 2026 Excellent Undergraduate Research Mentor Award for their exceptional leadership and support of student researchers.
Last week, the University of Kentucky Board of Trustees approved 17 University Research Professors for the 2026-27 academic year.
Two University of Kentucky Markey Cancer Center researchers have each received a Research Scholar Grant from the American Cancer Society (ACS), securing a combined $1.9 million to fund laboratory studies that may lead to new or more effective treatments for patients with few options.
For decades, the University of Kentucky’s Sanders-Brown Center on Aging has helped shape how the world understands Alzheimer’s disease and related dementias — from groundbreaking discoveries to leading clinical trials that are changing what’s possible for patients and families.
Where people live — and the air they breathe, green space they can access, and social and political conditions they experience — may play a major role in how the brain ages, according to a large international study recently published in Nature Medicine.
A new analytical system created by University of Kentucky researchers is helping to predict and prevent opioid overdoses in Kentucky.
After an intensive national search and selection process, UK HealthCare leadership announced Vedant Gupta, MD, has been selected as the director of the Gill Heart & Vascular Institute and leader of the cardiovascular health se
There’s a virus within a bacterium within a parasite, and University of Kentucky researchers are figuring out how to make them kill each other.
A new study co-authored by University of Kentucky Markey Cancer Center researchers Jessica Burris, PhD, Timothy Mullett, MD, and Graham Warren, MD, PhD, shows that making smoking cessation assistance a standard part of cancer care is achievable on a national scale and can happen relatively quickly.
A team of University of Kentucky researchers has uncovered a surprising clue in the battle against Alzheimer’s disease that could help doctors predict, and ultimately prevent, a common side effect of the newest generation of Alzheimer’s therapies.
A new University of Kentucky study has mapped areas across the U.S. where high rates of diabetes and deaths from diabetes-related cancers overlap.
A groundbreaking study identifying biological markers for schizophrenia could soon revolutionize how the disorder is diagnosed and treated in the Commonwealth and beyond.
Scientists at the University of Kentucky have uncovered a new reason why people with Alzheimer’s disease often struggle with sleep, long before memory loss begins. The study, led by researchers at the Sanders-Brown Center on Aging, reveals that a protein called tau “hijacks” the brain’s energy supply, keeping the brain in a state of overactive excitability that prevents restorative rest.
Each year UK Athletics, UK HealthCare and the UK Sanders-Brown Center on Aging partner for a game honoring legendary basketball coach Pat Summitt — a beloved leader and fierce Southeastern Conference competitor, who battled Alzheimer’s disease with remarkable courage.
For many Kentuckians with dementia, medical interventions may seem like the only choice, but a new University of Kentucky study shows that prioritizing joy and engagement through enrichment activities is vital for the health of both residents and the caregivers who support them.
The UK College of Medicine Office of Research 2025 Research Awards recognize faculty and staff who have made outstanding contributions to basic, clinical, and translational research in the College of Medicine. Please join us in congratulating the following awardees:
The University of Kentucky Markey Cancer Center has treated the first patient in the U.S. with a new immunotherapy for small cell lung cancer, offering hope for patients whose cancers have stopped responding to other treatments.
University of Kentucky Markey Cancer Centerradiation oncologist Denise Fabian, MD, will lead a national symposium focused on theranostics, a rapidly advancing approach to precision cancer care that combines diagnostic imaging and therapeutic interventions.
Imagine being able to see the invisible—amyloid plaques, tau tangles, and metabolic changes in the living brain. This is no longer science fiction; it’s reality at the University of Kentucky.